On April 21, Portland-based Rose City Laboratories, LLC (RCL) announced that it had been licensed by the Oregon Health Authority (OHA) to test psilocybin products for the state’s therapeutic centers. It’s the first lab to receive the required OHA license, but psilocybin treatment still can’t move forward.
In January, OHA opened its licensing applications for labs vying to test state-regulated psilocybin products, along with the manufacturers that will produce those products, the service centers where they’ll be consumed and the “trip facilitators” who will supervise the treatment sessions.
At publication time, OHA had not yet licensed any service centers. Meanwhile, only three manufacturers and four facilitators have so far received licenses. OHA is still expecting the first service centers to open their doors in 2023, but it’s not yet clear how widespread access will be at that time.
RCL will test psilocybin products for the two benchmarks of a regulated drug supply: potency and purity.
RCL began operating in 2012 and has been primarily known for testing cannabis. It began working toward psilocybin testing services in 2020, in anticipation of Measure 109—which legalized therapeutic psilocybin use at licensed service centers—being approved later that year. In January 2023, received Oregon’s first psilocybin lab accreditation, making it legally eligible for the OHA license it has now received.
Licensed manufacturers can formulate psilocybin as extracts, edibles or just the mushrooms themselves. Finished products are sent to RCL, which tests them for the two benchmarks of a regulated drug supply: potency and purity.
Hellbound and Down 
One thought on “Oregon Licenses First Psilocybin Lab, But Treatment Access Remains Stalled”